This study will collect real-world clinical and patient reported outcomes (PRO) and diary data from eligible patients with documented Human Epidermal Growth Factor Receptor 2 (HER2+) [globally] or HER2-low [North America only] in routine clinical practice.
page
...
Tufts Medical Center’s Hematology/Oncology Fellowship Program is an ACGME-accredited program that provides training in all aspects of hematology and oncology.